Unknown

Dataset Information

Probable tirofiban-induced thrombotic microangiopathy after stent thrombosis: a case report.


ABSTRACT:

Background

Glycoprotein (GP) IIb-IIIa inhibitors are antithrombotic drugs used in selected patients during and after percutaneous coronary interventions (PCIs), usually as a bail-out in the setting of no-reflow or thrombotic complications. A notorious life-threatening adverse effect of this drug class is immune-mediated drug-induced thrombocytopenia (DITP). Thrombotic microangiopathy (TMA) induced by GP IIb-IIIa inhibitors has never been reported.

Case summary

A 72-year-old woman admitted for anterior myocardial infarction treated with primary PCI and stent implantation underwent a first tirofiban infusion as a bail-out strategy. After a new procedure for stent thrombosis, she received a second tirofiban infusion and developed sudden severe thrombocytopenia (platelet count <

SUBMITTER: Mattioli M 

PROVIDER: S-EPMC9874025 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature